Sotalol Hydrochloride
Who holds supplier records for Sotalol Hydrochloride? 6 organisations hold a current record for Sotalol Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Italy (1), Germany (1) and Spain (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Sotalol Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sotalol-hydrochloride
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Sotalol Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Neuland Laboratories LimitedIndiaCEPActive DMF 14951 · latest filing Jul 2000
- APISYN HEALTHCARE PRIVATE LIMITEDIndiaActive DMF 43403 · latest filing Feb 2026
- CAMBREX PROFARMACO MILANO SRLItaly Company GMP cert on recordActive DMF 12273 · latest filing Dec 1996
- SIEGFRIED LTDActive DMF 3721 · latest filing Feb 1980
- Arevipharma GmbHGermanyCEP Company GMP cert on recordInactive DMF 23752 · latest filing Apr 2010
- SpainCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Sotalol Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2001-269 - Rev 11 Sotalol hydrochloride | Apr 2026 | — |
| Moehs Iberica S.L. Rubi | ES | CEP 2002-049 - Rev 08 Sotalol hydrochloride | Mar 2024 | — |
| AREVIPHARMA GMBH Radebeul | DE | CEP 2005-154 - Rev 04 Sotalol hydrochloride | Feb 2024 | Inspected Jun 2025 Germany |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Sotalol Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- SIFAVITOR SRLInactive DMF 14841 · filed Apr 2000
- HEUMANN PHARMA GMBHInactive DMF 13186 · filed Sept 1998
- Italy · Inactive DMF 13083 · filed Jul 1998
- IROTEC LABORATORIESInactive DMF 11887 · filed Mar 1996
- GANES CHEMICALS INC PENNSVILLE DIVInactive DMF 3754 · filed Mar 1980
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Sotalol Hydrochloride is a class III anti-arrhythmic agent that works by blocking potassium channels, which prolongs repolarization. It is used primarily to treat serious ventricular arrhythmias and to maintain normal sinus rhythm in patients with atrial fibrillation.
Chemical identity
- IUPAC name
- N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
- Canonical SMILES
- CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl
- InChIKey
- VIDRYROWYFWGSY-UHFFFAOYSA-N
- Synonyms
- Betapace API, betapace, darob, dl-mj-1999, mj 1999, mj-1999, nsc-337251, nsc-760358, sorine, sotacor, sotalex, sotalol hcl
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Antiarrhythmic
- Mechanism of action
- Adrenergic beta-Antagonists
- Physiologic effect
- Cardiac Rhythm Alteration
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Sotalol Hydrochloride?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Sotalol Hydrochloride: Neuland Laboratories Limited (India), APISYN HEALTHCARE PRIVATE LIMITED (India), CAMBREX PROFARMACO MILANO SRL (Italy), SIEGFRIED LTD, Arevipharma GmbH (Germany) and MOEHS IBERICA SL (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Sotalol Hydrochloride Drug Master Files are active?
Neuland Laboratories Limited (DMF 14951), APISYN HEALTHCARE PRIVATE LIMITED (DMF 43403), CAMBREX PROFARMACO MILANO SRL (DMF 12273) and SIEGFRIED LTD (DMF 3721). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Sotalol Hydrochloride records mean?
5 organisations have only inactive Type II DMFs for Sotalol Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Sotalol Hydrochloride have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Sotalol Hydrochloride on the EDQM register, including NEULAND LABORATORIES LIMITED Hyderabad (IN), Moehs Iberica S.L. Rubi (ES) and AREVIPHARMA GMBH Radebeul (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Sotalol Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Sotalol Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.